Literature DB >> 15527102

Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage.

Selcuk Peker1, Ufuk Abacioglu, Ibrahim Sun, Meral Yuksel, M Necmettin Pamir.   

Abstract

The aim of this study was to evaluate how timing of irradiation after brain surgery in rats relates to overall extent of brain radiation damage. Extent of injury was determined according to lipid peroxidation (malondialdehyde; MDA) levels in brain tissue. Thirty female rats were randomly assigned to five equal groups (Groups A-E). Four groups underwent trephination and scalpel hemisection of right frontal lobe. Rats in Groups B and D received 25 Gy cranial irradiation in a LINAC system at 10 and 20 days after surgery, respectively. Twenty-four hours later they were killed and their right frontal lobes were removed for lipid peroxidation determination. Groups A and C were not irradiated; these groups were killed and had their frontal lobes removed on day 11 and day 21 post-surgery, respectively. The remaining six animals (Group E, sham surgery) underwent trephination only, and were killed and had their frontal lobes removed 24 h later. There was a significant difference between the mean MDA levels in the control group and Group D, and between the levels in Group B and Group D (P < 0.05 for both). The difference between the mean for Group A and the mean for Group B was even more significant (P < 0.01). The most striking differences were between the control group and Group B, and between Group B and Group C (P < 0.001 for both). The data from this rat model suggest that, in humans, starting radiotherapy early (1-2 weeks) after debulking of a brain tumor may result in significantly higher levels of tissue damage than if the radiation is started 3 weeks or more postoperatively. Further experimental research is needed to project these findings in rats to human subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527102     DOI: 10.1023/b:neon.0000040820.78643.0a

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Stereotactic radiosurgery XIV: The role of the haemosiderin 'ring' in the development of adverse reactions following radiosurgery for intracranial cavernous malformations: a sustainable hypothesis.

Authors:  E J St George; J Perks; P N Plowman
Journal:  Br J Neurosurg       Date:  2002-08       Impact factor: 1.596

2.  The generation of superoxide radical during the autoxidation of hemoglobin.

Authors:  H P Misra; I Fridovich
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

3.  Radioprotective effects of the 21-aminosteroid U-74389G for stereotactic radiosurgery.

Authors:  D Kondziolka; S Somaza; A J Martinez; J Jacobsohn; A Maitz; L D Lunsford; J C Flickinger
Journal:  Neurosurgery       Date:  1997-07       Impact factor: 4.654

4.  Assay for blood plasma or serum.

Authors:  K Yagi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

Review 5.  Ferritin and haemosiderin in free radical generation, lipid peroxidation and protein damage.

Authors:  M J O'Connell; T J Peters
Journal:  Chem Phys Lipids       Date:  1987 Nov-Dec       Impact factor: 3.329

6.  Cerebral radioprotection by pentobarbital: dose-response characteristics and association with GABA agonist activity.

Authors:  J J Olson; R Friedman; K Orr; T Delaney; E H Oldfield
Journal:  J Neurosurg       Date:  1990-05       Impact factor: 5.115

7.  Effect of therapeutic ionizing radiation on the human brain.

Authors:  R G Steen; D Spence; S Wu; X Xiong; L E Kun; T E Merchant
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

8.  Antioxidant and iron-chelating agents in cerebral vasospasm.

Authors:  Z Luo; T Harada; S London; C Gajdusek; M R Mayberg
Journal:  Neurosurgery       Date:  1995-12       Impact factor: 4.654

9.  Reduction in radiation-induced brain injury by use of pentobarbital or lidocaine protection.

Authors:  E H Oldfield; R Friedman; T Kinsella; R Moquin; J J Olson; K Orr; A M DeLuca
Journal:  J Neurosurg       Date:  1990-05       Impact factor: 5.115

10.  The reduction of radiation damage to the spinal cord by post-irradiation administration of vasoactive drugs.

Authors:  S Hornsey; R Myers; T Jenkinson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-06       Impact factor: 7.038

View more
  17 in total

1.  Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

Authors:  Georges Noel; Aymeri Huchet; Loic Feuvret; Jean Philippe Maire; Pierre Verrelle; Emilie Le Rhun; Maud Aumont; François Thillays; Marie Pierre Sunyach; Chantal Henzen; Fernand Missohou; Renaud de Crevoisier; Pierre Yves Bondiau; Philippe Collin; Xavier Durando; Gilles Truc; Christine Kerr; Valérie Bernier; Jean-Baptiste Clavier; David Atlani; Anne D'Hombres; Sandrine Vinchon-Petit; Jean Léon Lagrange; Luc Taillandier
Journal:  J Neurooncol       Date:  2012-06-02       Impact factor: 4.130

Review 2.  Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?

Authors:  Yaacov Richard Lawrence; Deborah T Blumenthal; Diana Matceyevsky; Andrew A Kanner; Felix Bokstein; Benjamin W Corn
Journal:  J Neurooncol       Date:  2011-04-24       Impact factor: 4.130

Review 3.  Neuroprotection against surgically induced brain injury.

Authors:  Vikram Jadhav; Ihsan Solaroglu; Andre Obenaus; John H Zhang
Journal:  Surg Neurol       Date:  2007-01

4.  Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma.

Authors:  Alexander L Chin; Everett J Moding; Sarah S Donaldson; Iris C Gibbs; Scott G Soltys; Susan M Hiniker; Erqi L Pollom
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

5.  Impact of radiotherapy delay on survival in glioblastoma.

Authors:  Izaskun Valduvieco; Eugènia Verger; Jordi Bruna; Lluís Caral; Teresa Pujol; Teresa Ribalta; Teresa Boget; Laura Oleaga; Estela Pineda; Francesc Graus
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

6.  The evaluation of the oxidant injury as a function of time following brain irradiation in a rat model.

Authors:  Haldun Sükrü Erkal; Kadir Batçioğlu; Meltem Serin; Burçin Uyumlu; Neslihan Yücel
Journal:  Neurochem Res       Date:  2006-10       Impact factor: 3.996

7.  The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Authors:  Seunggu J Han; W Caleb Rutledge; Annette M Molinaro; Susan M Chang; Jennifer L Clarke; Michael D Prados; Jennie W Taylor; Mitchel S Berger; Nicholas A Butowski
Journal:  Neurosurgery       Date:  2015-08       Impact factor: 4.654

8.  Timing of radiotherapy in newly diagnosed glioblastoma: no need to rush?

Authors:  Marjolein Geurts; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

9.  The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma.

Authors:  Vanessa Montes Santos; Gustavo Nader Marta; Marcella Coelho Mesquita; Rossana Veronica Mendoza Lopez; Edla Renata Cavalcante; Olavo Feher
Journal:  J Neurooncol       Date:  2019-03-08       Impact factor: 4.130

Review 10.  Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.

Authors:  Seunggu J Han; Dario J Englot; Harjus Birk; Annette M Molinaro; Susan M Chang; Jennifer L Clarke; Michael D Prados; Jennie W Taylor; Mitchel S Berger; Nicholas A Butowski
Journal:  Neurosurgery       Date:  2015-08       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.